| Year |
Citation |
Score |
| 2024 |
Kirk AM, Crawford JC, Chou CH, Guy C, Pandey K, Kozlik T, Shah RK, Chung S, Nguyen P, Zhang X, Wang J, Bell M, Mettelman RC, Allen EK, Pogorelyy MV, ... ... Strome SE, et al. DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma. Cell Reports. Medicine. 5: 101469. PMID 38508137 DOI: 10.1016/j.xcrm.2024.101469 |
0.303 |
|
| 2019 |
Palechor-Ceron N, Krawczyk E, Dakic A, Simic V, Yuan H, Blancato J, Wang W, Hubbard F, Zheng YL, Dan H, Strome S, Cullen K, Davidson B, Deeken JF, Choudhury S, et al. Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks. Cells. 8. PMID 31717887 DOI: 10.3390/Cells8111327 |
0.351 |
|
| 2019 |
So EC, Khaladj-Ghom A, Ji Y, Amin J, Song Y, Burch E, Zhou H, Sun H, Chen S, Bentzen S, Hertzano R, Zhang X, Strome SE. NK cell expression of Tim-3: First impressions matter. Immunobiology. PMID 30876792 DOI: 10.1016/J.Imbio.2019.03.001 |
0.373 |
|
| 2019 |
Zandberg DP, Tallon LJ, Nagaraj S, Sadzewicz LK, Zhang Y, Strome MB, Zhao XE, Vavikolanu K, Zhang X, Papadimitriou JC, Hubbard FA, Bentzen SM, Strome SE, Fraser CM. Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity. Head & Neck. PMID 30869813 DOI: 10.1002/Hed.25719 |
0.348 |
|
| 2016 |
Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, ... ... Strome SE, et al. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. PMID 27906454 DOI: 10.1002/Cncr.30449 |
0.331 |
|
| 2016 |
Molitoris JK, Bentzen SM, Strome SE, Zandberg DP, Cullen KJ, Hanna N, Chuong MD. Overall Survival After Endoscopic Surgery Versus Radiation as the Initial Treatment in Oropharyngeal Squamous Cell Carcinoma International Journal of Radiation Oncology Biology Physics. 94: 892-893. DOI: 10.1016/J.Ijrobp.2015.12.090 |
0.308 |
|
| 2015 |
Sun W, Wang Y, East JE, Kimball AS, Tkaczuk K, Kesmodel S, Strome SE, Webb TJ. Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional. Cytokine. 72: 48-57. PMID 25569376 DOI: 10.1016/J.Cyto.2014.12.009 |
0.36 |
|
| 2014 |
Zandberg DP, Liu S, Goloubeva O, Ord R, Strome SE, Suntharalingam M, Taylor R, Morales RE, Wolf JS, Zimrin A, Lubek JE, Schumaker LM, Cullen KJ. Oropharyngeal cancer is a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center. Head & Neck. PMID 25488341 DOI: 10.1002/Hed.23933 |
0.363 |
|
| 2014 |
Chang AE, Ambro BT, Strome SE, Papadimitriou JC, Pereira KD. Immature teratoma of the maxillary sinus: a rare pediatric tumor. Jama Otolaryngology-- Head & Neck Surgery. 140: 870-2. PMID 25144659 DOI: 10.1001/Jamaoto.2014.1800 |
0.323 |
|
| 2014 |
Zandberg DP, Strome SE. The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck Oral Oncology. 50: 627-632. PMID 24819861 DOI: 10.1016/J.Oraloncology.2014.04.003 |
0.307 |
|
| 2014 |
Rapoport AP, Aqui NA, Stadtmauer EA, Vogl DT, Xu YY, Kalos M, Cai L, Fang HB, Weiss BM, Badros A, Yanovich S, Akpek G, Tsao P, Cross A, Mann D, ... ... Strome SE, et al. Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 1355-65. PMID 24520093 DOI: 10.1158/1078-0432.Ccr-13-2817 |
0.33 |
|
| 2014 |
Zandberg DP, Liu S, Goloubeva OG, Ord R, Strome SE, Suntharalingam M, Taylor R, Wolf JS, Zimrin A, Lubek JE, Schumaker LM, Cullen KJ. Oropharyngeal cancer (OPC) and racial outcome disparities in squamous cell carcinoma of the head and neck (HNSCC): Ten-year experience at the University of Maryland Greenebaum Cancer Center (UMGCC). Journal of Clinical Oncology. 32: 6083-6083. DOI: 10.1200/Jco.2014.32.15_Suppl.6083 |
0.337 |
|
| 2013 |
Jain A, Poonia B, So EC, Vyzasatya R, Burch EE, Olsen HS, Mérigeon EY, Block DS, Zhang X, Schulze DH, Hanna NN, Twadell WS, Yfantis HG, Chan SL, Cai L, ... Strome SE, et al. Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer. European Journal of Cancer (Oxford, England : 1990). 49: 3344-52. PMID 23871153 DOI: 10.1016/J.Ejca.2013.06.009 |
0.321 |
|
| 2013 |
So EC, Sallin MA, Zhang X, Chan SL, Sahni L, Schulze DH, Davila E, Strome SE, Jain A. A high throughput method for enrichment of natural killer cells and lymphocytes and assessment of in vitro cytotoxicity. Journal of Immunological Methods. 394: 40-8. PMID 23680234 DOI: 10.1016/J.Jim.2013.05.001 |
0.313 |
|
| 2013 |
Goding SR, Wilson KA, Xie Y, Harris KM, Baxi A, Akpinarli A, Fulton A, Tamada K, Strome SE, Antony PA. Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma. Journal of Immunology (Baltimore, Md. : 1950). 190: 4899-909. PMID 23536636 DOI: 10.4049/Jimmunol.1300271 |
0.367 |
|
| 2012 |
Voskens CJ, Sewell D, Hertzano R, DeSanto J, Rollins S, Lee M, Taylor R, Wolf J, Suntharalingam M, Gastman B, Papadimitriou JC, Lu C, Tan M, Morales R, Cullen K, ... ... Strome SE, et al. Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma. Head & Neck. 34: 1734-46. PMID 22287423 DOI: 10.1002/Hed.22004 |
0.313 |
|
| 2012 |
Park JJ, Anand S, Zhao Y, Matsumura Y, Sakoda Y, Kuramasu A, Strome SE, Chen L, Tamada K. Expression of anti-HVEM single-chain antibody on tumor cells induces tumor-specific immunity with long-term memory. Cancer Immunology, Immunotherapy : Cii. 61: 203-14. PMID 21877247 DOI: 10.1007/S00262-011-1101-8 |
0.371 |
|
| 2012 |
Suntharalingam M, Kwok Y, Goloubeva O, Parekh A, Taylor R, Wolf J, Zimrin A, Strome S, Ord R, Cullen KJ. Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck. International Journal of Radiation Oncology, Biology, Physics. 82: 1845-50. PMID 21601372 DOI: 10.1016/J.Ijrobp.2011.02.062 |
0.31 |
|
| 2012 |
Strongin A, Yovino S, Taylor R, Wolf J, Cullen K, Zimrin A, Strome S, Regine W, Suntharalingam M. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics. 82: 1823-30. PMID 21549516 DOI: 10.1016/J.Ijrobp.2010.10.053 |
0.381 |
|
| 2011 |
Fresnay S, Zhang X, Strome SE, Sewell DA. Bone marrow vaccination: A novel approach to enhance antigen specific antitumor immunity Vaccine. 29: 8599-8605. PMID 21951877 DOI: 10.1016/J.Vaccine.2011.09.022 |
0.318 |
|
| 2011 |
Zhang Y, Pfannenstiel LW, Bolesta E, Montes CL, Zhang X, Chapoval AI, Gartenhaus RB, Strome SE, Gastman BR. Interleukin-7 inhibits tumor-induced CD27 -CD28 - suppressor T cells: Implications for cancer immunotherapy Clinical Cancer Research. 17: 4975-4986. PMID 21712448 DOI: 10.1158/1078-0432.Ccr-10-3328 |
0.331 |
|
| 2011 |
Ertl HC, Zaia J, Rosenberg SA, June CH, Dotti G, Kahn J, Cooper LJ, Corrigan-Curay J, Strome SE. Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010. Cancer Research. 71: 3175-81. PMID 21531763 DOI: 10.1158/0008-5472.Can-10-4035 |
0.347 |
|
| 2010 |
Maniar A, Zhang X, Lin W, Gastman BR, Pauza CD, Strome SE, Chapoval AI. Human γδ T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement Blood. 116: 1726-1733. PMID 20519625 DOI: 10.1182/Blood-2009-07-234211 |
0.377 |
|
| 2010 |
Park JJ, Omiya R, Matsumura Y, Sakoda Y, Kuramasu A, Augustine MM, Yao S, Tsushima F, Narazaki H, Anand S, Liu Y, Strome SE, Chen L, Tamada K. B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance. Blood. 116: 1291-8. PMID 20472828 DOI: 10.1182/Blood-2010-01-265975 |
0.314 |
|
| 2010 |
Zhang X, Voskens CJ, Sallin M, Maniar A, Montes CL, Zhang Y, Lin W, Li G, Burch E, Tan M, Hertzano R, Chapoval AI, Tamada K, Gastman BR, Schulze DH, ... Strome SE, et al. CD137 promotes proliferation and survival of human B cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 787-95. PMID 20008291 DOI: 10.4049/Jimmunol.0901619 |
0.315 |
|
| 2009 |
Kottke T, Pulido J, Thompson J, Sanchez-Perez L, Chong H, Calderwood SK, Selby P, Harrington K, Strome SE, Melcher A, Vile RG. Antitumor immunity can be uncoupled from autoimmunity following heat shock protein 70-mediated inflammatory killing of normal pancreas. Cancer Research. 69: 7767-74. PMID 19738045 DOI: 10.1158/0008-5472.Can-09-1597 |
0.336 |
|
| 2009 |
Han J, Kioi M, Chu WS, Kasperbauer JL, Strome SE, Puri RK. Identification of potential therapeutic targets in human head & neck squamous cell carcinoma Head &Amp; Neck Oncology. 1: 27. PMID 19602232 DOI: 10.1186/1758-3284-1-27 |
0.373 |
|
| 2009 |
Settle K, Taylor R, Wolf J, Kwok Y, Cullen K, Carter K, Ord R, Zimrin A, Strome S, Suntharalingam M. Race impacts outcome in stage III/IV squamous cell carcinomas of the head and neck after concurrent chemoradiation therapy. Cancer. 115: 1744-52. PMID 19208429 DOI: 10.1002/Cncr.24168 |
0.342 |
|
| 2009 |
Taylor RJ, Chan SL, Wood A, Voskens CJ, Wolf JS, Lin W, Chapoval A, Schulze DH, Tian G, Strome SE. FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck. Cancer Immunology, Immunotherapy : Cii. 58: 997-1006. PMID 18979096 DOI: 10.1007/S00262-008-0613-3 |
0.358 |
|
| 2009 |
Strongin A, Yovino S, Taylor R, Wolf J, Cullen K, Ord R, Zimrin A, Strome S, Regine W, Suntharalingam M. Tumor Volume Predicts Tumor Control and Survival among Patients with Locally Advanced Head and Neck Cancer undergoing Definitive Chemoradiation Therapy International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.928 |
0.352 |
|
| 2008 |
Kottke T, Diaz RM, Kaluza K, Pulido J, Galivo F, Wongthida P, Thompson J, Willmon C, Barber GN, Chester J, Selby P, Strome S, Harrington K, Melcher A, Vile RG. Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1910-8. PMID 18827807 DOI: 10.1038/Mt.2008.212 |
0.349 |
|
| 2008 |
Alexander AA, Maniar A, Cummings JS, Hebbeler AM, Schulze DH, Gastman BR, Pauza CD, Strome SE, Chapoval AI. Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4232-40. PMID 18594005 DOI: 10.1158/1078-0432.Ccr-07-4912 |
0.341 |
|
| 2008 |
Lin W, Voskens CJ, Zhang X, Schindler DG, Wood A, Burch E, Wei Y, Chen L, Tian G, Tamada K, Wang LX, Schulze DH, Mann D, Strome SE. Fc-dependent expression of CD137 on human NK cells: insights into "agonistic" effects of anti-CD137 monoclonal antibodies. Blood. 112: 699-707. PMID 18519814 DOI: 10.1182/Blood-2007-11-122465 |
0.311 |
|
| 2008 |
Montes CL, Chapoval AI, Nelson J, Orhue V, Zhang X, Schulze DH, Strome SE, Gastman BR. Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion. Cancer Research. 68: 870-9. PMID 18245489 DOI: 10.1158/0008-5472.Can-07-2282 |
0.39 |
|
| 2007 |
Wood AH, Zhang X, Farber DL, Strome SE. CD8+ memory T lymphocytes from bone marrow--immune function and therapeutic potential. Critical Reviews in Immunology. 27: 527-37. PMID 18197798 DOI: 10.1615/Critrevimmunol.V27.I6.30 |
0.331 |
|
| 2007 |
Strome SE, Sausville EA, Mann D. A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects Oncologist. 12: 1084-1095. PMID 17914078 DOI: 10.1634/Theoncologist.12-9-1084 |
0.322 |
|
| 2007 |
Wolf JS, Li G, Varadhachary A, Petrak K, Schneyer M, Li D, Ongkasuwan J, Zhang X, Taylor RJ, Strome SE, O'Malley BW. Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1601-10. PMID 17332307 DOI: 10.1158/1078-0432.Ccr-06-2008 |
0.402 |
|
| 2007 |
Zhang X, Moche JA, Farber D, Strome SE. Vaccine-based approaches to squamous cell carcinoma of the head and neck Oral Diseases. 13: 17-22. PMID 17241425 DOI: 10.1111/J.1601-0825.2006.01329.X |
0.318 |
|
| 2007 |
Kupferman ME, Rhee JS, Alexander AAZ, Amudhan M, Pauza CD, Strome SE, Chapoval AI. 11:40: Potent Anti-Tumor Activity of gd T Cells towards Human HNSCC Otolaryngology-Head and Neck Surgery. 137. DOI: 10.1016/J.Otohns.2007.06.102 |
0.348 |
|
| 2007 |
Settle K, Taylor R, Wolf J, Kwok Y, Cullen K, Carter K, Ord R, Zimrin A, Strome S, Suntharalingam M. Race Impacts Outcome in Stage III/IV Squamous Cell Carcinomas of the Head and Neck Following Concurrent Chemoradiation Therapy International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.364 |
0.333 |
|
| 2007 |
Carter K, Settle K, Taylor R, Wolf J, Kwok Y, Cullen K, Ord R, Zimrin A, Strome S, Suntharalingam M. Site as a Prognostic Factor in Patients With Stage III/IV Squamous Cell Carcinoma of the Head and Neck Following Definitive Chemoradiation International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.1658 |
0.342 |
|
| 2007 |
Foote RL, Foote RT, Brown PD, Garces YI, Okuno SH, Strome SE. Erratum: Organ preservation for advanced laryngeal carcinoma (Head and Neck (2006) 28 (689-696) DOI: 10.1002/hed.20387) Head and Neck-Journal For the Sciences and Specialties of the Head and Neck. 29. DOI: 10.1002/Hed.20595 |
0.31 |
|
| 2006 |
Zhang X, Dong H, Lin W, Voss S, Hinkley L, Westergren M, Tian G, Berry D, Lewellen D, Vile RG, Chen L, Farber DL, Strome SE. Human bone marrow: a reservoir for "enhanced effector memory" CD8+ T cells with potent recall function. Journal of Immunology (Baltimore, Md. : 1950). 177: 6730-7. PMID 17082586 DOI: 10.4049/Jimmunol.177.10.6730 |
0.326 |
|
| 2005 |
Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Strome SE, Leibovich BC, Kwon ED. 618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target The Journal of Urology. 173: 169-169. DOI: 10.1016/S0022-5347(18)34858-4 |
0.337 |
|
| 2004 |
Foote RL, Kasperbauer JL, Okuno SH, Nichols DA, Brown PD, Garces YI, Sargent DJ, Strome SE. High dose intra-arterial cisplatin with concomitant accelerated radiotherapy for patients with T4 and selected T3, N0-3, M0 head and neck cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 5528. PMID 28013953 DOI: 10.1200/Jco.2004.22.14_Suppl.5528 |
0.324 |
|
| 2004 |
Zhang X, Strome SE. B7-H1-targeted immunotherapy for head and neck cancer Expert Opinion On Biological Therapy. 4: 1577-1583. PMID 15461569 DOI: 10.1517/14712598.4.10.1577 |
0.336 |
|
| 2004 |
Lai JP, Chien J, Strome SE, Staub J, Montoya DP, Greene EL, Smith DI, Roberts LR, Shridhar V. HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene. 23: 1439-47. PMID 14973553 DOI: 10.1038/Sj.Onc.1207258 |
0.331 |
|
| 2004 |
Strome SE, Chen L. Costimulation-based immunotherapy for head and neck cancer Current Treatment Options in Oncology. 5: 27-33. PMID 14697154 DOI: 10.1007/S11864-004-0003-9 |
0.356 |
|
| 2003 |
Phan V, Errington F, Cheong SC, Kottke T, Gough M, Altmann S, Brandenburger A, Emery S, Strome S, Bateman A, Bonnotte B, Melcher A, Vile R. A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines. Nature Medicine. 9: 1215-9. PMID 12925849 DOI: 10.1038/Nm923 |
0.346 |
|
| 2003 |
Silverman DA, El-Hajj M, Strome S, Esclamado RM. Prevalence of nodal metastases in the submuscular recess (level IIb) during selective neck dissection Archives of Otolaryngology - Head and Neck Surgery. 129: 724-728. PMID 12874072 DOI: 10.1001/Archotol.129.7.724 |
0.361 |
|
| 2003 |
Kienstra MA, Neel HB, Strome SE, Roche P. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma. Head & Neck. 25: 457-63. PMID 12784237 DOI: 10.1002/Hed.10223 |
0.415 |
|
| 2003 |
Graner DE, Foote RL, Kasperbauer JL, Stoeckel RE, Okuno SH, Olsen KD, Sabri AN, Maragos NE, Cha SS, Sargent DJ, Strome SE. Swallow function in patients before and after intra-arterial chemoradiation. The Laryngoscope. 113: 573-9. PMID 12616217 DOI: 10.1097/00005537-200303000-00033 |
0.31 |
|
| 2003 |
Dong H, Strome SE, Matteson EL, Moder KG, Flies DB, Zhu G, Tamura H, Driscoll CLW, Chen L. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis Journal of Clinical Investigation. 111: 363-370. PMID 12569162 DOI: 10.1172/Jci16015 |
0.318 |
|
| 2002 |
Brissett AE, Olsen KD, Kasperbauer JL, Lewis JE, Goellner JR, Spotts BE, Weaver AL, Strome SE. Merkel cell carcinoma of the head and neck: a retrospective case series. Head & Neck. 24: 982-8. PMID 12410532 DOI: 10.1002/Hed.10153 |
0.348 |
|
| 2002 |
Wilcox RA, Tamada K, Strome SE, Chen L. Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity. Journal of Immunology (Baltimore, Md. : 1950). 169: 4230-6. PMID 12370353 DOI: 10.4049/Jimmunol.169.8.4230 |
0.329 |
|
| 2002 |
Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nature Medicine. 8: 793-800. PMID 12091876 DOI: 10.1038/Nm730 |
0.349 |
|
| 2002 |
Strome SE, Weinman EC. Advanced larynx cancer Current Treatment Options in Oncology. 3: 11-20. PMID 12057083 DOI: 10.1007/S11864-002-0037-9 |
0.321 |
|
| 2002 |
Gostout BS, Strome SE, Clayton AC, McGovern RM, Olsen KD, Webb MJ. Two cases of coincident carcinomas of the head and neck and the uterine cervix. Gynecologic Oncology. 85: 376-80. PMID 11972404 DOI: 10.1006/Gyno.2002.6618 |
0.322 |
|
| 2002 |
Wilcox RA, Flies DB, Zhu G, Johnson AJ, Tamada K, Chapoval AI, Strome SE, Pease LR, Chen L. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. The Journal of Clinical Investigation. 109: 651-9. PMID 11877473 DOI: 10.1172/Jci14184 |
0.377 |
|
| 2002 |
Strome SE, Martin E, Flies D, Khurana D, Salomao D, Tamada K, Chapoval AI, Kasperbauer JL, Olsen KD, Chen L. Reassessment of CD62L as a marker of pre-effector T cells in the tumor draining lymph nodes of head and neck cancer patients. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 126: 180-7. PMID 11870350 DOI: 10.1067/Mhn.2002.122263 |
0.377 |
|
| 2001 |
Khurana D, Martin EA, Kasperbauer JL, O'Malley BW, Salomao DR, Chen L, Strome SE. Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy. Head & Neck. 23: 899-906. PMID 11592238 DOI: 10.1002/Hed.1130 |
0.391 |
|
| 2000 |
Strome SE, Martin B, Flies D, Tamada K, Chapoval AI, Sargent DJ, Shu S, Chen L. Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanoma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 23: 430-7. PMID 10916752 DOI: 10.1097/00002371-200007000-00006 |
0.382 |
|
| 1999 |
Strome SE, To W, Strawderman M, Gersten K, Devaney KO, Bradford CR, Esclamado RM. Squamous cell carcinoma of the buccal mucosa. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 120: 375-9. PMID 10064641 DOI: 10.1016/S0194-5998(99)70278-0 |
0.346 |
|
| Show low-probability matches. |